COPD and Asthma

Welcome Message

We are delighted to invite participants from around the globe to the “4^th International Conference on COPD and Asthma”, taking place on June 11–12, 2026, in Rome, Italy. Centered around the theme “Advancing COPD Care: Stronger Lungs, Healthier Lives”, this prestigious event will unite leading experts, researchers, healthcare professionals, and industry representatives to discuss the latest innovations in COPD management and respiratory health.

COPD Summit 2026 will offer a dynamic and well-rounded program, featuring keynote sessions, oral and poster presentations, exhibitions, and engaging panel discussions. Attendees will also benefit from interactive workshops designed to encourage hands-on learning and meaningful collaboration. With both in-person and virtual participation options available, the conference ensures broad accessibility for a truly global audience.

Together, we aim to enhance the quality of care and support for individuals affected by COPD, asthma, and other lung diseases worldwide. We warmly welcome your participation in this inspiring event, which promises to foster insightful dialogue, ground breaking research, and continued progress in respiratory healthcare.

About Conference

The 4^th International Conference on COPD and Asthma (COPD Summit 2026) will be held on June 11–12, 2026, in Rome, Italy, under the theme “Advancing COPD Care: Stronger Lungs, Healthier Lives.” This international event brings together researchers, clinicians, and healthcare professionals committed to enhancing respiratory health and advancing care for COPD and asthma patients.

The conference focuses on promoting awareness and expanding knowledge about respiratory diseases while offering participants opportunities to present research, gain new insights, and build professional connections. With an emphasis on innovation and patient-centered care, it will serve as a platform to discuss current challenges, emerging trends, and future directions in COPD management and lung health.

Attendees will benefit from expert-led sessions, interactive discussions, and exposure to the latest technologies in the field. Renowned speakers will share practical expertise and research advancements, while all participants will receive certificates recognizing their contribution. Through collaboration and knowledge exchange, COPD Summit 2026 aims to support progress in respiratory medicine and improve patient outcomes worldwide.

Featured at COPD SUMIT 2026 

• Workshops: Hands-on sessions led by leading experts.
• Keynote & Plenary Sessions: Inspiring talks from global thought leaders.
• Young Researcher’s Forum: A platform for emerging scientists to share innovative ideas.
• Symposium: Focused discussions on critical topics in COPD, Asthma and Lung Health.
• Exhibitor Booths: Explore cutting-edge technologies, products, and services.
• Dedicated B2B Meeting Room: Facilitate networking and collaborations.
• Research Excellence Award: Honoring outstanding contributions in COPD research.
• Best Poster Competition: Showcase groundbreaking work and win recognition.
• Young Scientist Award: Celebrating promising talent and impactful research.

Join us at COPD SUMMIT 2026  to engage, innovate, and transform the future of COPD and Lung Health care!

Why to attend

Join a distinguished gathering of global experts, clinicians, and researchers dedicated to advancing care in COPD, asthma, and pulmonary health. This conference provides an exceptional platform to explore the latest innovations, research developments, and clinical practices shaping the future of respiratory medicine.

The program covers a wide range of topics, including COPD management, asthma care, respiratory diseases, pulmonary rehabilitation, lung transplantation, pediatric pulmonology, and lung cancer diagnosis and treatment. Over two days, attendees can present research, engage in discussions, and connect with peers worldwide, gaining insights into emerging therapies and building valuable professional networks.

Target Audience:

• Research Scientists
• Pulmonologists, Respiratory Therapists
• Lung and respiratory Researchers
• Pulmonology Faculty and Students
• Lung and Respiratory Associations and Societies
• Thoracic Surgeons, Radiologists
• Cardiologists
• Physicians/Consultants/ General Practitioners
• Medical and Nursing Professors and Students
• Pathologists
• COPD Associations/ Societies
• Training Institutes
• Directors/CEO & Business Entrepreneurs
• Pharmaceutical companies
• Manufacturing Medical Device Companies
• Pulmonary Medicine and surgery-related Companies
• Health Care Professionals, Healthcare Administrator

Abstact Submission and Registration

Speakers from around the world are invited to submit their abstracts, papers, case studies, posters, and e-posters by selecting a topic from the "Sessions and Tracks" or their area of research interest.

Abstract Guidelines:

1. The abstract length must not exceed 500 words.
2. The title should be written in sentence case.
3. Include the full name of the author and co-authors (if any), along with their affiliation.
4. Provide a short biography of the author (limited to 150 words) and a photograph.

Review Process:

1. All abstracts will be reviewed by the Scientific Committee Members.
2. Feedback or acceptance notifications will be sent via email within 24-48 hours after submission.

Publication:

 All accepted abstracts will be published in the conference proceedings in the respective journal.

 Abstract Submission URL: https://copd.annualcongress.com/abstract-submission.php

Registration:

COPD Summit 2026 is a premier platform dedicated to exploring groundbreaking discoveries and innovative approaches in COPD and lung healthcare. This two-day event brings together global experts to encourage meaningful discussions, knowledge sharing, and collaboration, featuring world-renowned keynote speakers who deliver cutting-edge insights to advance clinical practice and research. Open to doctors, physicians, scientists, academicians, educators, students, sponsors, exhibitors, and organizations, the summit offers valuable opportunities for all participants. With flexible and affordable registration options, including webinar access, and exclusive hotel packages, the conference ensures a convenient and enriching experience for a diverse international audience.

How To Register

Visit the Register Now page to explore options and secure your spot today. Don't miss this chance to be part of a transformative event in Pulmonary health care.

Sessions & Tracks

Track 1: COPD: Advances & Management

COPD: Advances & Management focuses on the latest advancements in the understanding, diagnosis, and management of Chronic Obstructive Pulmonary Disease (COPD). It will highlight emerging therapies, innovative treatment strategies, and recent clinical research aimed at improving patient outcomes and quality of life. Key discussions will include pharmacological interventions, pulmonary rehabilitation, early diagnosis techniques, and personalized care approaches. The session will also address challenges in COPD management, including comorbidities and disease progression. Attendees will gain valuable insights from experts on best practices, new technologies, and evidence-based approaches shaping the future of COPD care and long-term disease management.

Track 2: Asthma: New Insights & Therapies

Asthma: New Insights & Therapies highlights the latest developments in the understanding and treatment of asthma, focusing on innovative therapies and evolving clinical practices. It will explore advances in the pathophysiology of asthma, including the role of inflammation and immune responses, along with breakthroughs in biologics and targeted treatments. Discussions will cover early diagnosis, personalized treatment plans, and strategies to improve disease control and patient adherence. Experts will also address environmental triggers, prevention methods, and emerging technologies in asthma care. This session aims to provide participants with updated knowledge and practical approaches to enhance asthma management and patient outcomes.

• Advances in Asthma Pathophysiology
• Biologic Therapies & Targeted Treatments
• Pediatric & Geriatric Asthma Care
• Asthma Prevention & Risk Reduction

Track 3: Asthma COPD Overlap (ACO)

Asthma-COPD Overlap (ACO) focuses on a complex condition with features of both asthma and COPD. It highlights challenges in accurate diagnosis using clinical history, spirometry, and biomarkers. The session will emphasize personalized treatment strategies, including inhaled corticosteroids, bronchodilators, and combination therapies to improve patient outcomes. Key discussions will cover risk factors, comorbidities, and exacerbation management. Experts will share evidence-based practices and real-world case studies to enhance clinical decision-making. Attendees will gain practical insights and updated approaches for effective diagnosis, treatment, and long-term management of ACO in diverse healthcare settings.

Track 4: COPD Pathogenesis

COPD Pathogenesis focuses on the underlying mechanisms and biological processes involved in the development of Chronic Obstructive Pulmonary Disease (COPD). It will explore the role of chronic inflammation, oxidative stress, genetic susceptibility, and environmental exposures such as tobacco smoke and air pollution. Discussions will highlight cellular and molecular pathways contributing to airway remodeling and lung tissue damage. Experts will also examine disease progression, early pathological changes, and potential therapeutic targets. This session aims to provide a deeper understanding of COPD pathogenesis, enabling the development of more effective prevention strategies and targeted treatments to improve patient outcomes.

Track 5: Respiratory Infections

Respiratory Infections on the role of respiratory infections in lung health, particularly their impact on conditions such as COPD and asthma. It will cover common bacterial, viral, and fungal infections, including their transmission, diagnosis, and management. Discussions will highlight the link between infections and disease exacerbations, as well as prevention strategies such as vaccination and infection control. Experts will present advances in diagnostic tools, antimicrobial therapies, and emerging treatment approaches. Attendees will gain practical insights into early detection, effective management, and reducing the burden of respiratory infections in clinical practice.

• Bacterial Respiratory Infections
• Advances in Diagnostic Technologies
• Vaccination & Preventive Strategies
• Fungal Lung Infections

Track 6: Pneumonia & Tuberculosis

Pneumonia & Tuberculosis explores on two major respiratory infections, pneumonia and tuberculosis, highlighting their global impact, diagnosis, and management. It will cover advances in early detection methods, imaging techniques, and laboratory diagnostics, along with current treatment protocols and drug resistance challenges. Discussions will also address risk factors, prevention strategies, and public health approaches, especially in high-burden regions. Experts will share insights on vaccination, antimicrobial therapies, and patient care practices. Attendees will gain practical knowledge to improve clinical outcomes and effectively manage pneumonia and tuberculosis in diverse healthcare settings.

Track 7: Pulmonary Hypertension

Pulmonary Hypertension, a serious condition characterized by increased pressure in the pulmonary arteries affecting heart and lung function. It will cover advances in early diagnosis, imaging techniques, and hemodynamic assessment. Discussions will highlight underlying causes, disease classification, and risk factors, along with the latest treatment options including targeted therapies and combination approaches. Experts will also address disease progression, patient management, and long-term care strategies. Attendees will gain practical insights into improving diagnosis, optimizing treatment, and enhancing quality of life for patients with pulmonary hypertension.

Track 8: Lung Fibrosis

Lung Fibrosis, a progressive condition characterized by scarring of lung tissue that leads to reduced respiratory function. It will cover the latest insights into disease mechanisms, risk factors, and early diagnostic approaches, including imaging and biomarker analysis. Discussions will highlight advances in antifibrotic therapies, supportive care, and emerging treatment strategies. Experts will also address disease progression, complications, and patient-centered management. Attendees will gain practical knowledge on improving early detection, optimizing treatment plans, and enhancing quality of life for patients with lung fibrosis.

• Pathophysiology of Lung Fibrosis
• Advances in Diagnostic Imaging
• Multidisciplinary & Patient-Centered Care
• Idiopathic Pulmonary Fibrosis (IPF)

Track 9: Cystic Fibrosis

Cystic fibrosis, a genetic disorder that affects the lungs and other organs, leading to persistent respiratory infections and reduced lung function. It will cover advances in early diagnosis, genetic screening, and understanding of disease mechanisms. Discussions will highlight innovative therapies, including CFTR modulators, airway clearance techniques, and infection management strategies. Experts will also address multidisciplinary care, nutritional support, and long-term patient management. Attendees will gain valuable insights into improving clinical outcomes, enhancing quality of life, and adopting the latest evidence-based approaches in cystic fibrosis care.

Track 10: Sleep Apnea

Sleep apnea, a common sleep-related breathing disorder characterized by repeated interruptions in breathing during sleep. It will cover types of sleep apnea, including obstructive and central sleep apnea, along with risk factors and associated complications such as cardiovascular issues. Discussions will highlight advances in diagnostic methods like polysomnography and home sleep testing, as well as treatment options including CPAP therapy, oral appliances, and lifestyle modifications. Experts will also address patient adherence and long-term management strategies. Attendees will gain practical insights into improving diagnosis, treatment, and overall patient outcomes.

Track 11: Bronchoscopy & Airway Techniques

Bronchoscopy & Airway Techniques explores bronchoscopy and advanced airway management techniques used in the diagnosis and treatment of respiratory conditions. It will cover flexible and rigid bronchoscopy, endobronchial ultrasound (EBUS), and other minimally invasive procedures for airway evaluation. Discussions will highlight their role in diagnosing lung diseases, tumors, infections, and airway obstructions. Experts will also address therapeutic interventions such as stenting, biopsy, and foreign body removal. Emphasis will be placed on procedural safety, innovation, and clinical best practices. Attendees will gain practical knowledge to enhance diagnostic accuracy and improve patient outcomes in respiratory care.

• Flexible & Rigid Bronchoscopy
• Therapeutic Bronchoscopy
• Safety, Sedation & Clinical Best Practices
• Endobronchial Ultrasound (EBUS) & Advanced Imaging

Track 12: Interventional Pulmonology

Interventional Pulmonology, a rapidly evolving field focused on minimally invasive procedures for the diagnosis and treatment of complex lung diseases. It will cover advanced techniques such as endobronchial ultrasound (EBUS), navigational bronchoscopy, airway stenting, and pleural interventions. Discussions will highlight their role in managing lung cancer, airway obstruction, pleural diseases, and other respiratory conditions. Experts will also address procedural safety, patient selection, and emerging technologies. Attendees will gain practical insights into innovative interventions, improving diagnostic precision and enhancing therapeutic outcomes in modern pulmonary care.

Track 13: Lung Cancer: Diagnosis & Treatment

Lung Cancer: Diagnosis & Treatment explores the latest advancements in the diagnosis and treatment of lung cancer, one of the leading causes of cancer-related mortality worldwide. It will cover early detection strategies, imaging techniques, and molecular diagnostics that enable accurate staging and personalized treatment planning. Discussions will highlight current treatment approaches, including surgery, chemotherapy, targeted therapy, and immunotherapy. Experts will also address multidisciplinary care, patient management, and emerging innovations in lung cancer research. Attendees will gain valuable insights into improving early diagnosis, optimizing treatment strategies, and enhancing patient outcomes in lung cancer care.

Track 14: AI in Respiratory Care

AI in Respiratory Care focuses the transformative role of artificial intelligence in respiratory care, highlighting its impact on diagnosis, treatment, and patient management. It will cover AI-driven tools in imaging analysis, predictive analytics, and early disease detection for conditions such as COPD, asthma, and lung cancer. Discussions will also address machine learning applications in clinical decision support, remote monitoring, and personalized treatment planning. Experts will examine challenges related to data integration, ethics, and implementation in healthcare systems. Attendees will gain insights into how AI is enhancing accuracy, efficiency, and outcomes in modern respiratory medicine.

• AI in Imaging & Diagnostics
• Predictive Analytics & Clinical Decision Support
• Remote Monitoring & Personalized Care
• Data Integration, Ethics & Implementation

Track 15: Personalized Pulmonary Medicine

Personalized Pulmonary Medicine, focusing on tailored approaches to the prevention, diagnosis, and treatment of respiratory diseases. It will cover the role of genetics, biomarkers, and advanced diagnostics in customizing therapies for conditions such as COPD, asthma, and lung cancer. Discussions will highlight precision medicine strategies, targeted treatments, and patient-specific care plans that improve outcomes and reduce adverse effects. Experts will also address data-driven decision-making and emerging technologies. Attendees will gain valuable insights into delivering individualized care and advancing precision approaches in respiratory healthcare.

Track 16: COPD Diagnosis & Guidelines

COPD Diagnosis & Guidelines explores the latest standards and best practices in the diagnosis and management of Chronic Obstructive Pulmonary Disease (COPD). It will cover updated clinical guidelines, including the use of spirometry, imaging, and symptom assessment tools for accurate diagnosis and staging. Discussions will highlight evidence-based treatment pathways, risk stratification, and management of exacerbations. Experts will also address guideline implementation in clinical practice and challenges in early detection. Attendees will gain practical insights into applying current recommendations to improve diagnosis, optimize treatment strategies, and enhance patient outcomes in COPD care.

Track 17: COPD Pharmacotherapy

Pharmacological management of Chronic Obstructive Pulmonary Disease (COPD), focusing on current and emerging drug therapies. It will cover the use of bronchodilators, inhaled corticosteroids, combination therapies, and novel agents aimed at improving lung function and reducing exacerbations. Discussions will highlight personalized treatment approaches, drug selection based on disease severity, and patient response. Experts will also address medication adherence, side effects, and optimization of inhaler techniques. Attendees will gain practical insights into evidence-based pharmacotherapy strategies to enhance treatment effectiveness and improve quality of life for COPD patients.

• Bronchodilators & Inhaled Therapies
• Personalized Pharmacotherapy in COPD
• Emerging Drugs & Novel Therapeutics
• Adherence, Safety & Inhaler Techniques

Track 18: Next-Gen COPD Treatments

Next-Gen COPD Treatments explores emerging and next-generation therapies transforming the management of Chronic Obstructive Pulmonary Disease (COPD). It will cover innovative approaches such as biologics, regenerative medicine, gene-based therapies, and advanced drug delivery systems. Discussions will highlight ongoing clinical trials, novel targets for treatment, and breakthroughs aimed at slowing disease progression and improving patient outcomes. Experts will also address challenges in accessibility, safety, and long-term effectiveness. Attendees will gain insights into future treatment landscapes and cutting-edge innovations that are shaping the next era of COPD care.

Track 19: Non-Invasive Ventilation (NIV)

Non-Invasive Ventilation (NIV) focuses the role of non-invasive ventilation (NIV) in managing acute and chronic respiratory failure. It will cover key modalities such as CPAP and BiPAP, along with their clinical applications in conditions like COPD exacerbations, sleep apnea, and respiratory distress. Discussions will highlight patient selection, initiation protocols, and monitoring strategies to ensure optimal outcomes. Experts will also address challenges such as patient tolerance, complications, and adherence. Attendees will gain practical insights into effective NIV use, improving respiratory support and enhancing patient care in both hospital and home settings.

Track 20: Lung Transplantation

Lung transplantation as a life-saving treatment option for patients with end-stage lung diseases. It will cover patient selection criteria, pre-transplant evaluation, and advances in surgical techniques. Discussions will highlight post-transplant care, immunosuppressive therapies, and the management of complications such as rejection and infection. Experts will also address long-term outcomes, ethical considerations, and organ allocation challenges. Attendees will gain valuable insights into improving patient selection, optimizing perioperative care, and enhancing survival and quality of life for lung transplant recipients.

• Patient Selection & Pre-Transplant Evaluation
• Surgical Techniques & Perioperative Management
• Post-Transplant Care & Complication Management
• Long-Term Outcomes, Ethics & Organ Allocation

Track 21: Pulmonary Rehabilitation

Pulmonary rehabilitation as a comprehensive, multidisciplinary approach to improving the quality of life for patients with chronic respiratory diseases. It will cover exercise training, breathing techniques, nutritional support, and patient education aimed at enhancing physical capacity and symptom control. Discussions will highlight rehabilitation strategies for COPD, asthma, and post-COVID conditions, along with approaches to improve patient adherence and long-term outcomes. Experts will also address home-based and community rehabilitation programs. Attendees will gain practical insights into designing and implementing effective pulmonary rehabilitation programs for better patient care.

Track 22: Pediatric Respiratory Care

Pediatric Respiratory Care explores respiratory care in infants and children, focusing on the diagnosis and management of common and complex pediatric lung conditions. It will cover disorders such as asthma, bronchiolitis, pneumonia, and congenital lung diseases. Discussions will highlight age-specific diagnostic approaches, treatment strategies, and advances in pediatric respiratory support. Experts will also address preventive care, vaccination, and long-term management to improve child health outcomes. Attendees will gain practical insights into delivering effective, child-centered respiratory care and enhancing clinical practices in pediatric pulmonology.

Track 23: COPD & Cardiovascular Diseases

Chronic Obstructive Pulmonary Disease (COPD) and cardiovascular diseases, highlighting their shared risk factors and clinical impact. It will cover conditions such as hypertension, heart failure, and ischemic heart disease commonly associated with COPD. Discussions will focus on pathophysiological links, early detection, and integrated management strategies. Experts will address the impact of comorbidities on disease progression, treatment outcomes, and patient quality of life. Attendees will gain valuable insights into coordinated care approaches that improve both respiratory and cardiovascular health outcomes.

• Cardiovascular Comorbidities in COPD
• Pathophysiological Links & Shared Risk Factors
• Integrated Diagnosis & Management Strategies
• Impact on Outcomes & Patient-Centered Care

Track 24: Air Pollution & Tobacco Control

Air Pollution & Tobacco Control focuses the impact of air pollution and tobacco use on respiratory health, with a focus on prevention and control strategies. It will cover the role of environmental pollutants, occupational exposures, and smoking in the development and progression of diseases such as COPD, asthma, and lung cancer. Discussions will highlight public health policies, smoking cessation programs, and global initiatives aimed at reducing exposure and disease burden. Experts will also address awareness, regulatory measures, and community interventions. Attendees will gain practical insights into prevention strategies and policy-driven approaches to improve lung health outcomes.

Track 25: COPD Prevention & Self-Management

COPD Prevention & Self-Management explores effective strategies for preventing Chronic Obstructive Pulmonary Disease (COPD) and empowering patients in self-management. It will cover risk reduction approaches such as smoking cessation, minimizing exposure to air pollutants, and early screening for high-risk populations. Discussions will highlight patient education, lifestyle modifications, medication adherence, and the use of digital health tools for monitoring symptoms. Experts will also address action plans for managing exacerbations and improving daily quality of life. Attendees will gain practical insights into promoting prevention and supporting patients in long-term, self-directed COPD care.

• Prevention & Risk Reduction Strategies
• Exacerbation Management & Quality of Life
• Patient Education & Self-Management Practices
• Adherence, Monitoring & Digital Health Tools

Market Analysis

The global Chronic Obstructive Pulmonary Disease (COPD) market is experiencing significant growth, driven by the increasing prevalence of respiratory diseases and rising exposure to risk factors such as tobacco smoking, air pollution, and occupational hazards. COPD, which includes chronic bronchitis and emphysema, is a leading cause of morbidity and mortality worldwide, creating a strong demand for effective diagnosis, treatment, and long-term management solutions.

The market is primarily driven by the growing use of pharmacological treatments, including bronchodilators, corticosteroids, and combination therapies, which remain the first line of treatment for managing symptoms and improving patient quality of life. Additionally, increasing healthcare expenditure, advancements in diagnostic techniques, and greater public awareness are contributing to market expansion. Hospitals dominate the end-user segment due to the availability of advanced infrastructure, skilled professionals, and comprehensive care facilities.

Regionally, North America holds the largest market share, supported by strong research and development activities, advanced healthcare systems, and the presence of major industry players. Meanwhile, emerging economies in Asia-Pacific and other developing regions are expected to witness rapid growth due to improving healthcare access, rising awareness, and increasing investments in healthcare infrastructure.

Benefits of Participation

COPD Summit 2026 offers diverse participation opportunities for academic, student, and business professionals. The available categories include:

1. Keynote Speaker: 45–50 minutes presentation
2. Speaker (Oral Presentation): 25–30 minutes (individual presenter)
3. Speaker (Workshop): 45–50 minutes (multiple presenters allowed)
4. Speaker (Special Session): 45–50 minutes (multiple presenters allowed)
5. Speaker (Symposium): More than 45 minutes (multiple presenters allowed)
6. Delegate: Access to all sessions with full registration benefits
7. Poster Presenter: Present a poster and receive delegate benefits
8. Virtual Attendance: Participate via video presentation or e-poster
9. Exhibitor: Showcase products/services through exhibition booths
10. Media Partner
11. Sponsor
12. Collaborator

Advantages of Participating in Our Conference

1. Participants will receive CPD credits along with a certificate of participation.
2. Speaker and abstract profiles indexed by search engines enhance global visibility and professional recognition.
3. Our abstract library attracts over 30,000 monthly visits and 50,000 views, increasing exposure for speakers and researchers.
4. Opportunities for interactive meetings are available, especially for groups attending with research teams.
5. Connect and exchange ideas with leading experts in COPD, asthma, and lung health.
6. Recognition through awards such as Young Scientist Award and Best Poster Certificate.
7. Engage in meaningful one-on-one discussions with distinguished speakers and keynote experts.
8. Gain insights from keynote sessions featuring world-renowned authorities in COPD and pulmonary healthcare.

Benefits of Participation for Speakers

1. All accepted abstracts will be published in relevant journals, enhancing academic recognition.
2. Participants will receive CPD credits along with an official certificate of participation.
3. Gain global visibility and recognition for your research profile.
4. Earn valuable points toward your professional development.
5. Explore the latest cutting-edge research and scientific advancements.
6. Build lasting connections through networking and social interactions.
7. Promote your work through abstract books and flyers, reaching a wide audience and strengthening your research impact.
8. Expand your knowledge by exploring interdisciplinary topics beyond COPD, asthma, and lung health.
9. Experience a well-balanced event that combines networking, learning, and engaging activities.

Benefits of Participation for Delegates

1. Enhance knowledge and skills to support continuous professional development.
2. Stay refreshed, motivated, and inspired by attending engaging conference sessions and webinars.
3. Gain new perspectives and innovative approaches that can be applied to improve professional or organizational outcomes.
4. Connect with scholars and practitioners in COPD, lung health, and respiratory fields to exchange ideas and insights.

Benefits of Participation for Sponsors

1. Enhance brand visibility and expand business opportunities in the global marketplace.
2. Showcase your latest innovations, products, and services to an international audience.
3. Generate high-quality leads and build valuable business connections.
4. Network with like-minded professionals, industry leaders, and potential partners to support business growth.
5. Gain insights and fresh perspectives from COPD and asthma-focused conferences and webinars to strengthen your strategies.
6. Benchmark your organization against industry leaders and explore opportunities for advancement.
7. Address business challenges and gain expert insights through direct interaction with trusted professionals at the conference.

Benefits of Participation for Collaborators

1. Gain exceptional visibility through a high-traffic platform, making COPD Summit 2026 an ideal venue to promote your organization.
2. Build strong, long-term professional relationships with peers and industry experts.
3. Enhance brand presence through logo placement, promotional materials, and conference branding, helping expand your audience and membership base.
4. Increase global recognition by positioning your organization within an international business and research forum.
5. Enable your representatives to engage with key delegates, improving awareness and understanding of your services.
6. Receive promotional exposure through inclusion in conference materials such as posters, brochures, and pamphlets distributed to hospitals, universities, researchers, and the public.